Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

279 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study.
Majchrzak-Stiller B, Buchholz M, Peters I, Strotmann J, Möhrke J, Zelichowski L, Oehlke L, Quensel C, Fein D, Höhn P, Müller T, Uhl W, Braumann C. Majchrzak-Stiller B, et al. Among authors: peters i. J Cancer Res Clin Oncol. 2023 Sep;149(11):9071-9083. doi: 10.1007/s00432-023-04799-8. Epub 2023 May 12. J Cancer Res Clin Oncol. 2023. PMID: 37171614 Free PMC article.
New Therapy Options for Neuroendocrine Carcinoma of the Pancreas-The Emergent Substance GP-2250 and Gemcitabine Prove to Be Highly Effective without the Development of Secondary Resistances In Vitro and In Vivo.
Buchholz M, Strotmann J, Majchrzak-Stiller B, Hahn S, Peters I, Horn J, Müller T, Höhn P, Uhl W, Braumann C. Buchholz M, et al. Among authors: peters i. Cancers (Basel). 2022 May 29;14(11):2685. doi: 10.3390/cancers14112685. Cancers (Basel). 2022. PMID: 35681665 Free PMC article.
GP-2250, a novel anticancer agent, inhibits the energy metabolism, activates AMP-Kinase and impairs the NF-kB pathway in pancreatic cancer cells.
Majchrzak-Stiller B, Buchholz M, Peters I, Waschestjuk D, Strotmann J, Höhn P, Hahn S, Braumann C, Uhl W, Müller T, Möhler H. Majchrzak-Stiller B, et al. Among authors: peters i. J Cell Mol Med. 2023 Jul;27(14):2082-2092. doi: 10.1111/jcmm.17825. Epub 2023 Jun 30. J Cell Mol Med. 2023. PMID: 37390227 Free PMC article.
Challenges in Pharmacokinetic Modelling of [18F]fluoro-PEG-folate PET/CT Imaging in Epithelial Ovarian Cancer Patients.
Ruytenberg T, Ciggaar IA, Peters ITA, Noortman WA, Dibbets-Schneider P, de Muynck LDAN, Kuil J, de Kroon CD, Molenaar TJM, Helmerhorst HJF, Pereira Arias-Bouda LM, Vahrmeijer AL, Windhorst AD, van Velden FHP, Gaarenstroom KN, de Geus-Oei LF. Ruytenberg T, et al. Among authors: peters ita. Mol Imaging Biol. 2024 May 22. doi: 10.1007/s11307-024-01922-0. Online ahead of print. Mol Imaging Biol. 2024. PMID: 38775919
Fracture and relaxation in dense cornstarch suspensions.
Lilin P, Elkhoury JE, Peters IR, Bischofberger I. Lilin P, et al. Among authors: peters ir. PNAS Nexus. 2023 Dec 22;3(1):pgad451. doi: 10.1093/pnasnexus/pgad451. eCollection 2024 Jan. PNAS Nexus. 2023. PMID: 38222467 Free PMC article.
279 results